Oncoinvent ASA
OCIN | Euronext Growth
Overview
Corporate Details
- ISIN(s):
- NO0010779341 (+1 more)
- LEI:
- 54930076H5GUZRMSNR39
- Country:
- Norway
- Address:
- Gullhaugveien 7, 0484 Oslo
- Website:
- https://www.oncoinvent.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Oncoinvent ASA is a Norwegian biotechnology company developing targeted radiopharmaceuticals to provide innovative treatments for cancer patients worldwide.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-04 13:53 |
Post-Annual General Meeting Information
Oncoinvent shareholders approve the merger plan with BerGenBio - Attachment: On…
|
Norwegian | 111.8 KB | |
| 2025-08-04 13:53 |
Post-Annual General Meeting Information
Oncoinvent shareholders approve the merger plan with BerGenBio
|
English | 4.4 KB | |
| 2025-07-03 15:45 |
Pre-Annual General Meeting Information
Oncoinvent ASA: Notice of Extraordinary General Meeting - Attachment: Oncoinven…
|
Norwegian | 190.2 KB | |
| 2025-07-03 15:45 |
Pre-Annual General Meeting Information
Oncoinvent ASA: Notice of Extraordinary General Meeting
|
English | 3.6 KB | |
| 2025-06-30 22:11 |
Share Issue/Capital Change
Announcement of fully underwritten rights issue - Attachment: Attachment_overvi…
|
English | 101.2 KB | |
| 2025-06-30 22:11 |
Share Issue/Capital Change
Announcement of fully underwritten rights issue - Attachment: Joint_Press_Relea…
|
English | 143.1 KB | |
| 2025-06-30 22:11 |
Share Issue/Capital Change
Announcement of fully underwritten rights issue
|
English | 20.6 KB | |
| 2025-06-30 22:01 |
M&A Activity
BerGenBio and Oncoinvent, a rising innovator in radiopharmaceutical cancer ther…
|
English | 136.0 KB | |
| 2025-06-30 22:01 |
M&A Activity
BerGenBio and Oncoinvent, a rising innovator in radiopharmaceutical cancer ther…
|
English | 19.0 KB | |
| 2025-06-18 08:01 |
Legal Proceedings Report
Oncoinvent (ONCIN): Invitation to Presentation of Positive Final Data from Phas…
|
English | 134.6 KB | |
| 2025-06-18 08:01 |
Report Publication Announcement
Oncoinvent (ONCIN): Invitation to Presentation of Positive Final Data from Phas…
|
English | 3.7 KB | |
| 2025-06-18 07:00 |
Earnings Release
Oncoinvent Announces Positive Final Data from Phase 1/2a Trial of Radspherin® i…
|
English | 230.2 KB | |
| 2025-06-18 07:00 |
Regulatory News Service
Oncoinvent Announces Positive Final Data from Phase 1/2a Trial of Radspherin® i…
|
English | 7.2 KB | |
| 2025-05-14 12:39 |
Post-Annual General Meeting Information
Minutes from the annual general meeting 2025
|
Norwegian | 1.5 MB | |
| 2025-05-14 12:39 |
Post-Annual General Meeting Information
Minutes from the annual general meeting 2025
|
English | 1.6 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
genOway | France | ALGEN | |
|
GenSight Biologics S.A. | France | SIGHT | |
|
Gentian Diagnostics ASA | Norway | GENT | |
|
Genus PLC | United Kingdom | GNS | |
|
Grace Breeding Ltd. | Israel | GRAC | |
|
Group 107 Ltd. | Israel | G107 | |
|
Guard Therapeutics International AB | Sweden | GUARD | |
|
Gubra A/S | Denmark | GUBRA | |
|
Hadasit Bio Holding Ltd. | Israel | HDST-M | |
|
Hansa Biopharma | Sweden | HNSA |